Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ambrx, Inc.

Clinical trials sponsored by Ambrx, Inc., explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

Develops engineered protein therapeutics using non-natural amino acids.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1

New hope for advanced breast cancer: experimental drug targets tumors after other treatments fail

Disease control Ongoing

This study tests an experimental drug called ARX788 in people with HER2-positive breast cancer that has spread and no longer responds to standard treatments. About 72 adults will receive the drug to see if it shrinks tumors and how long that effect lasts. The goal is to find a ne…

Phase: PHASE2 • Sponsor: Ambrx, Inc. • Aim: Disease control

Last updated Jun 27, 2026 11:00 UTC